Livzon Pharmaceutical Group Inc.s Stock Has Been Sliding But Fundamentals Look Strong Is The Market Wrong - Simply Wall St
| LP6 Stock | EUR 3.40 0.18 5.59% |
Roughly 55% of LIVZON PHARMAC's stockholders are presently thinking to get in. The analysis of current outlook of investing in LIVZON PHARMAC GRP suggests that some traders are interested regarding LIVZON PHARMAC's prospects. The current market sentiment, together with LIVZON PHARMAC's historical and current headlines, can help investors time the market. In addition, many technical investors use LIVZON PHARMAC GRP stock news signals to limit their universe of possible portfolio assets.
LIVZON PHARMAC stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of LIVZON daily returns and investor perception about the current price of LIVZON PHARMAC GRP as well as its diversification or hedging effects on your existing portfolios.
LIVZON |
Livzon Pharmaceutical Group Inc.s Stock Has Been Sliding But Fundamentals Look Strong Is The Market Wrong Simply Wall St
Read at news.google.com
 |
LIVZON PHARMAC Fundamental Analysis
We analyze LIVZON PHARMAC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LIVZON PHARMAC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LIVZON PHARMAC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
LIVZON PHARMAC is rated fourth overall in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
LIVZON PHARMAC GRP Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LIVZON PHARMAC stock to make a market-neutral strategy. Peer analysis of LIVZON PHARMAC could also be used in its relative valuation, which is a method of valuing LIVZON PHARMAC by comparing valuation metrics with similar companies.
Peers
LIVZON PHARMAC Related Equities
| LP6 | LIVZON PHARMAC | 5.59 | ||||
| EVT | Evotec SE | 0.12 | ||||
| R2WA | BEXIMCO PHARMAGDR | 0.00 | ||||
| MRK | Merck KGaA | 0.25 | ||||
| DMP | Dermapharm Holding | 0.53 | ||||
| H6D | Haleon PLC | 0.55 | ||||
| S2P | SIMCERE PHARMAC | 1.22 | ||||
| BSFA | ANI Pharmaceuticals | 1.92 | ||||
| CJH | CanSino Biologics | 3.17 |
Complementary Tools for LIVZON Stock analysis
When running LIVZON PHARMAC's price analysis, check to measure LIVZON PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LIVZON PHARMAC is operating at the current time. Most of LIVZON PHARMAC's value examination focuses on studying past and present price action to predict the probability of LIVZON PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LIVZON PHARMAC's price. Additionally, you may evaluate how the addition of LIVZON PHARMAC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |